GAL and cancer: In this study, to our knowledge, we investigated the IgG terminal galactosylated N-glycans in BPD for the first time and found that Gal-ratio showed no significant difference in BPD and healthy control and demonstrated high potential in discrimination of PC from non-cancer group.